Dr. Summer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
834 Walnut St
Ste 650
Philadelphia, PA 19107Phone+1 215-955-5161Fax+1 215-923-6003
Summary
- Dr. Ross Summer is a pulmonologist in Philadelphia, PA and is affiliated with Thomas Jefferson University Hospitals. He received his medical degree from Louisiana State University School of Medicine and has been in practice 21 years. He specializes in critical care and respiratory medicine with specific focus on the care and treatment of patients with interstitial lung disease. He has more than 100 publications and approximately 7500 citings.
Education & Training
Boston University Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1999 - 2003
Johns Hopkins UniversityResidency, Internal Medicine, 1996 - 1999
Louisiana State University School of Medicine in New OrleansClass of 1996
Certifications & Licensure
PA State Medical License 2011 - 2024
MA State Medical License 1999 - 2014
Awards, Honors, & Recognition
- Patient-Centered Specialty Practice Recognition Program National Committee for Quality Assurance, 2014-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
Clinical Trials
- Autoantibody Reduction for Acute Exacerbations of Idiopathic Pulmonary Fibrosis Start of enrollment: 2018 Sep 04
Roles: Contact
Publications & Presentations
PubMed
- Mortality and Health Outcomes Among Patients With Sarcoidosis Treated With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers.Joseph Fares, Omar El Fadel, Joy Zhao, Jianxin Sun, Jesse Roman
Chest. 2024-09-21 - Pressed for understanding: Interstitial lung disease in dry-cleaning workers.Ross Summer, Phoebe Chun
The American Journal of the Medical Sciences. 2024-09-03 - Letter to the editor in response to article "Use of statins in patients with established idiopathic inflammatory myopathies".Joseph Fares, Ross Summer, Giorgos Loizidis
Clinical Rheumatology. 2024-07-01
Press Mentions
Hermansky-Pudlak Syndrome-2 Alters Mitochondrial Homeostasis in the Alveolar Epithelium of the LungFebruary 8th, 2021
Increasing Lipid Production Could Be Key to New Pulmonary Fibrosis Treatment, Study SaysMarch 12th, 2018
Grant Support
- Adiponectin Inhibits Activation And Injury Of Lung EndotheliumNational Heart, Lung, And Blood Institute2011
- The Identification And Study Of A Lung Mesenchymal Stem CellNational Heart, Lung, And Blood Institute2007–2010
- The Identification And Study- Lung Mesenchymal Stem CellNational Heart, Lung, And Blood Institute2006
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
